Pharma-Care, Inc. / The Rasa Group, Inc
Corporate & Billing Office: 500 Craig Road, Suite 104, Manalapan, NJ 07726
Operations Office: 136 Central Avenue, Suite 202, Clark, NJ 07066
Main Phone - (732) 574-9015 -:- Clark Fax: 732-499-6778 -:- Manalapan Fax: 856-807-5915
2024/2025 © Pharma-Care, Inc. Privacy
The CDC has endorsed the Advisory Committee on Immunization Practices’ (ACIP) recommendation for updated COVID-19 boosters that add Omicron BA.4 and BA.5 spike protein components to the mRNA COVID-19 vaccine composition. These updated COVID-19 boosters offer stronger protection against severe illness and death from Omicron sub-variants.
The CDC is re-framing the definition of what it means to be up-to date with COVID-19 vaccination. Individuals are up to date if they have a completed a primary series and received the most recent booster dose recommended by the CDC.
Individuals ages 12 and older are encouraged to get a COVID-19 bivalent booster dose which should be received two months after their most recent booster or primary vaccination series.
• The new Pfizer bivalent booster is recommended for all individuals ages 12 and older.
• The Moderna bivalent booster is recommended for those ages 18 and older.
Monovalent mRNA COVID-19 vaccines are NO LONGER authorized for use as boosters in people ages 12 years and older.
Individuals should not receive a bivalent booster without first completing a primary series.
Providers should continue to administer the monovalent boosters to children 5 through 11 years of age who are eligible since the bivalent booster is not yet authorized for this age group.
COVID-19 vaccines may be administered without regard to timing of other vaccines. COVID-19 vaccines can be co-administered with the influenza vaccine at the same visit.
Disclaimer: COVID-19 information is current as of September 9, 2022. Recommendations subject to change based on guidance from the CDC and ACIP.
Simplified Vaccination Schedule
Detailed Vaccination Schedules (based on if patient is immunocompromised):
NOTES:
*3-8 interval for Novavax and Pfizer-BioNTech; 4-8 interval for Moderna
† The bivalent booster dose is administered at least 2 months after completion of the primary series.
For people who previously received a monovalent booster dose(s), the bivalent booster dose is administered at least 2 months after the last monovalent booster dose. The bivalent booster should be age appropriate; Pfizer-BioNTech is authorized for people ages 12 years and older and Moderna is authorized for people 18 years and older.
Updated COVID-19 Boosters Available
Contact Pharma-Care to set up
a COVID-19 booster clinic.
The New Jersey Department of Health has requested Pharma-Care, Inc. to work with and assist in the COVID-19 booster vaccination program to all health care facilities. For additional information on how Pharma-Care can help your facility, please contact:
Maureen Ziegler, Asst Director Education
Booster Clinic Coordinator
mziegler@pharmacareinc.com
732-943-3527 or 732-574-9015 x 105